Latest filing published 24 Dec 2025 for Fennec Pharmaceuticals INC., €104k.
Filing timeline
BuySaleInsider track record
Southpoint Capital Advisors LP: trading record in brief
Southpoint Capital Advisors LP appears in our data through filings on Fennec Pharmaceuticals Inc. shares, published by SEC (Form 4). We count 8 filings; the first trade dates from 4 May 2020 and the latest from 24 December 2025.
On the market, this insider has only sold: 7 sales, €6.4M in total. 2025 to date brings no purchases and 7 sales.
The latest filing, published on 24 December 2025, reports an open-market sale of €104k in Fennec Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Southpoint Capital Advisors LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,341 shares@ CA$8.79210.8% of flowCommon SharesTSXSEDI:4628221
- 1,000,000 shares@ CA$7.5036.9% of flowCommon SharesTSXSEDI:4628232
- 85,918 shares@ CA$8.78973.3% of flowCommon SharesTSXSEDI:4607179
- 160,100 shares@ CA$7.99775.5% of flowCommon SharesTSXSEDI:4607176
- 26,900 shares@ CA$9.58711.1% of flowCommon SharesTSXSEDI:4590581
- 19,605 shares@ CA$9.47020.8% of flowCommon SharesTSXSEDI:4590585
- 20,609 shares@ CA$9.34610.8% of flowCommon SharesTSXSEDI:4590587
- 80,000 shares@ CA$6.252.2% of flowCommon SharesTSXSEDI:3546262
8 of 8 declarations
